CASE 3-3 HEALTH CARE Abbott Laboratories and Subsidiaries* CONSOLIDATED BALANCE SHEET (IN PART) (Dollars in thousands) December 31 2008 2007 2006 Liabilities and Shareholders' Investment Current Liabilities: Short-term borrowings Trade accounts payable Salaries, wages, and commissions Other accrued liabilities Dividends payable Income taxes payable Obligation in connection with conclusion of TAP 1,691,069 1,351,436 1,011,312 4,216,742 559,064 805,397 1,827,361 1,219,529 859,784 3,713,104 504,540 80,406 S 5,305,985 1,175,590 807,283 3,850,723 453,994 262,344 Pharmaceutical Products, Inc. joint venture Current portion of long-term debt Total Current Liabilities Long-term Debt Postemployment Obligations and Other Long-term 915,982 1,040,906 11,591,908 8,713,327 898,554 95,276 9,103,278 11,951,.195 7,009,664 9,487,789 4,634,418 317 3,163,127 Liabilities Commitments and Contingencies Shareholders' Investment: Preferred shares, one dollar par value *Abbott Laboratories is an Illinois corporation, incorporated in 1900, Abbott's principal business is the discovery, develop- ment, manufacture, and sale of a broad and diversified line of health care products." 10-K